“Yoshioka et al. studied the effect of melatonin administration on the release of 5-hydroxytryptamine , 5-HIAA, DOPAC (3, 4-dihydroxyphenylacetic acid), and HVA in the suprachiasmatic nuclei of rats and reported that the release of the 5-HT metabolite and 5-HIAA was significantly reduced by this treatment.”